Stratus Therapeutics

Cambridge, MA · Founded 2021 · Privately Held (backing)

Operator of a biotech company intended to treat patients with blood, bone marrow, immune, and metabolic diseases. Stratus Therapeutics is based in Cambridge, MA and was founded in 2021. Its last reported valuation was $210 million in Jan 2023. It has raised $184 million.

Last reported valuation

$210.0M

Oct 2026

Priced at

—

Total raised

$184.1M

Last round

—

How much has Stratus Therapeutics raised?

$184.1Macross 0 recorded rounds

Free account

More of Stratus Therapeutics with a free account

·The complete investor list: 13 names
·Watch Stratus Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Stratus Therapeutics investors

13 investors are on record for Stratus Therapeutics, including Alexandria Venture Investments, OrbiMed, Cormorant Asset Management and Monashee Investment Management. By type, the record holds 3 venture capital firms, 1 hedge fund and 1 growth equity firm.

For fundraisers

Raising for a company like Stratus Therapeutics?

13 investors have backed Stratus Therapeutics.

See all 13 investors →

Frequently asked about Stratus Therapeutics

How much has Stratus Therapeutics raised?: Stratus Therapeutics has raised $184.1M in total across 0 recorded funding rounds.